1. Designing multi-epitope based peptide vaccine candidates against SARS-CoV-2 using immunoinformatics approach

Ysrafil Ysrafil* , Zulfiayu Sapiun , Indwiani Astuti , Mohammad Anas Anasiru, Nangsih Sulastri Slamet , Hartati Hartati , Fadli Husain, Sukmawati Ahmad Damiti

BioImpacts. 2022;12(4): 359-370. doi: 10.34172/bi.2022.23769

PMCID: PMC9376164 PMID: 35975206 Scopus ID: 85138027836

Article

PDF

Suppl 1

Full Text

XML

Cited By:

The two designed and constructed multiepitope vaccine have good characteristics and may have the potential to activate humoral and cellular immune responses against SARS-CoV-2. Further research is worth considering to confirm the findings of this study.

Original Article

2. Mosaic vaccine design targeting mutational spike protein of SARS- CoV-2: An immunoinformatics approach

Ysrafil Ysrafil , Arlan K. Imran, Prisca Syafriani Wicita, Vyani Kamba, Fihrina Mohamad, Ismail Ismail, Ayyub Harly Nurung, Noviyanty Indjar Gama, Sari Eka Pratiwi, Indwiani Astuti , Firzan Nainu, Talha Bin Emran

Bioimpacts. 2025;15: 26443 | Published on: 2024 Apr 22. doi: 10.34172/bi.2023.26443

Article

PDF

Suppl 1

Full Text

XML

Cited By:

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 20%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of COPE
Follower of ICMJE
Permission: Creative Commons